Posted On: 08/16/2014 11:22:48 AM
Post# of 74542
$SLXP Recent Headlines
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
Charting the approach of S&P 2,000 11:06 a.m. July 24, 2014 - Michael Ashbaugh
Another good find in specialty pharma 12:17 p.m. July 3, 2014 - The Trading Deck
S&P, Dow press uncharted territory 8:22 a.m. June 23, 2014 - Michael Ashbaugh
Playing defense in a market in transition 3:08 p.m. April 29, 2014 - The Trading Deck
Stock leaders flex muscles 2:58 p.m. Feb. 27, 2014 - The Trading Deck
The case for the bears weakens 2:55 p.m. Feb. 25, 2014 - The Trading Deck
2 leading growth stocks setting up for a move 2:29 p.m. Dec. 24, 2013 - The Trading Deck
S&P shifts to ‘good news is good news’ backdrop 1:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Nasdaq Composite rattles cage on the 4,000 mark 12:29 p.m. Nov. 25, 2013 - Michael Ashbaugh
FDA clears Salix anti-diarrheal for HIV patients 7:59 a.m. Jan. 1, 2013 - MarketWatch.com
Salix Pharmaceuticals profit rises 8:27 a.m. Aug. 9, 2012 - MarketWatch.com
Hot Stocks to watch 7:27 a.m. Aug. 9, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:15 p.m. July 30, 2012 - MarketWatch
Progenics, Salix shares hit by FDA rejection 11:29 a.m. July 30, 2012 - Val Brickates Kennedy
Progenics, Salix tumble on FDA drug rejection 10:46 a.m. July 30, 2012 - Val Brickates Kennedy
LNKD trade provides a teachable moment 12:02 a.m. March 22, 2012 - The Trading Deck
Tuesday’s biggest gaining and declining stocks 5:58 p.m. Dec. 20, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 6:17 p.m. Nov. 9, 2011 - Kate Gibson
S&P 500 nails trendline resistance 11:44 a.m. Oct. 7, 2011 - Michael Ashbaugh
Trouble For Synergy Pharmaceuticals Shorts With Pending SP-333 Trial Results 7:24 p.m. Aug. 15, 2014 - Seeking Alpha
3 Health Care Stocks Pushing The Sector Higher 1:03 p.m. Aug. 15, 2014 - TheStreet.com
Watch For Today's Momo Momentum Stock: Salix Pharmaceuticals (SLXP) 10:17 a.m. Aug. 15, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ACT AGN GILD IRWD 9:00 a.m. Aug. 15, 2014 - InvestorPlace.com
Why Tax Inversions Won't Go Away 2:20 p.m. Aug. 13, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – INCY WST BIIB SLXP 1:45 p.m. Aug. 13, 2014 - InvestorPlace.com
Salix Pharmaceuticals, Ltd. (SLXP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 13, 2014 - Zacks.com
Repros Therapeutics Q2 Loss a Penny Wider than Expected - Analyst Blog 10:50 a.m. Aug. 12, 2014 - Zacks.com
Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog 9:20 a.m. Aug. 12, 2014 - Zacks.com
Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog 11:50 a.m. Aug. 11, 2014 - Zacks.com
Inversion Deals Are Costing The U.S. 8:58 a.m. Aug. 11, 2014 - Seeking Alpha
Leaders Actavis, Salix Trip Sell Signals 5:37 p.m. Aug. 8, 2014 - Investors Business Daily
Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales - Analyst Blog 4:10 p.m. Aug. 8, 2014 - Zacks.com
OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 8.2% - Tale of the Tape 9:39 a.m. Aug. 8, 2014 - Zacks.com
IGI, Laboratories (IG) Jumps: Stock Adds 6.7% in Session - Tale of the Tape 8:51 a.m. Aug. 8, 2014 - Zacks.com
Salix Sinks In #PreMarket On Disappointing Outlook, Q2 Results 8:19 a.m. Aug. 8, 2014 - benzinga.com
Sterne Agee Adjusts Estimates For Salix Pharmaceuticals 8:17 a.m. Aug. 8, 2014 - benzinga.com
Salix Pharmaceuticals' (SLXP) CEO Carolyn Logan on Q2 2014 Results - Earnings Call Transcript 8:10 p.m. Aug. 7, 2014 - Seeking Alpha
Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide 5:50 p.m. Aug. 7, 2014 - Investors Business Daily
Salix Pharmaceuticals (SLXP) Q2 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 7, 2014 - Seeking Alpha
Corporate Statements, Supplemental New Drug Application, Financial Result, and Technical Update - Research Reports on Allergan, Salix, Medivation, Valeant and AstraZeneca 9:20 a.m. Aug. 13, 2014 - PR Newswire - PRF
Salix Announces Important Topline Results for Microbiome, Culture & Susceptibility, and Key Secondary Efficacy Results for TARGET 3, Rifaximin IBS-D Repeat Treatment Study 2:01 p.m. Aug. 11, 2014 - BusinessWire - BZX
FDA Assigns September 29, 2014 Prescription Drug User Fee Act Goal Date for RELISTOR® Subcutaneous Injection sNDA for the Treatment of Opioid-induced Constipation in Patients with Chronic Non-cancer Pain 7:00 a.m. Aug. 11, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Reports 2Q2014 Results 4:02 p.m. Aug. 7, 2014 - BusinessWire - BZX
Lifshitz & Miller Law Firm Announces Investigation of Design Within Reach, Inc., Family Dollar Stores, Inc., GFI Group Inc., Intermountain Community Bancorp, Rockwood Holdings, Inc., and Salix Pharmaceuticals Ltd. 1:19 p.m. July 31, 2014 - PR Newswire - PRF
Salix Pharmaceuticals Announces 2Q2014 Financial Results Conference Call and Webcast 7:00 a.m. July 24, 2014 - BusinessWire - BZX
Pharma Stocks under Review -- Impax Laboratories, Sanofi, GW Pharma, AcelRx Pharma, and Salix Pharma 9:20 a.m. July 23, 2014 - PR Newswire - PRF
Salix and Pharming Announce FDA Approval of RUCONEST® for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE) 1:00 a.m. July 17, 2014 - BusinessWire - BZX
Progenics Holds Conference Call This Morning on FDA Appeal Response Regarding Relistor(R) sNDA for Patients With Chronic Non-Cancer Pain 7:05 a.m. July 14, 2014 - GlobeNewswire
FDA Office of Drug Evaluation III Approves Salix’s Request that the FDA Approve the RELISTOR® Subcutaneous Injection sNDA for the Treatment of Opioid-induced Constipation in Patients with Chronic Non-cancer Pain 7:00 a.m. July 14, 2014 - BusinessWire - BZX
Drug Application Submission, Merger Agreement, Launch of Newly Approved Drug, and Acquisition - Analyst Notes on Actavis, Salix, Mylan, Zoetis and Hospira 5:10 a.m. July 14, 2014 - PR Newswire - PRF
SALIX PHARMACEUTICALS, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger 11:42 a.m. July 10, 2014 - PR Newswire - PRF
SALIX SHAREHOLDER ALERT:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Merger between Salix and Cosmo Pharmaceuticals May be Unfair to Shareholders 11:30 a.m. July 10, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Salix Pharmaceuticals, Ltd. In Connection With The Proposed Sale Of The Company 6:10 p.m. July 9, 2014 - BusinessWire - BZX
SALIX ALERT: Proposed Sale of Salix Pharmaceuticals, Ltd. Being Investigated by Johnson & Weaver, LLP 1:32 p.m. July 9, 2014 - BusinessWire - BZX
Cadwalader Advising Salix Pharmaceuticals in its Combination with Cosmo Technologies to Form Salix Pharmaceuticals, plc 9:05 p.m. July 8, 2014 - BusinessWire - BZX
Salix Pharmaceuticals to Combine with Cosmo Technologies to Form Salix Pharmaceuticals, plc 5:00 p.m. July 8, 2014 - BusinessWire - BZX
Salix Announces Statistically Significant Primary Endpoint Result for TARGET 3 Evaluating the Efficacy and Safety of Repeat Treatment with Rifaximin 550mg in Subjects with Irritable Bowel Syndrome with Diarrhea 7:00 a.m. July 1, 2014 - BusinessWire - BZX
Patent Case Settlements, FDA Rulings, Upcoming Investor Day, Product Launching, and Closing of Offering - Analyst Notes on Teva, AstraZeneca, Salix, Mylan and GW 5:10 a.m. June 30, 2014 - PR Newswire - PRF
Salix Pharmaceuticals to Host Investor Day on July 9, 2014 7:00 a.m. June 25, 2014 - BusinessWire - BZX
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
Charting the approach of S&P 2,000 11:06 a.m. July 24, 2014 - Michael Ashbaugh
Another good find in specialty pharma 12:17 p.m. July 3, 2014 - The Trading Deck
S&P, Dow press uncharted territory 8:22 a.m. June 23, 2014 - Michael Ashbaugh
Playing defense in a market in transition 3:08 p.m. April 29, 2014 - The Trading Deck
Stock leaders flex muscles 2:58 p.m. Feb. 27, 2014 - The Trading Deck
The case for the bears weakens 2:55 p.m. Feb. 25, 2014 - The Trading Deck
2 leading growth stocks setting up for a move 2:29 p.m. Dec. 24, 2013 - The Trading Deck
S&P shifts to ‘good news is good news’ backdrop 1:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Nasdaq Composite rattles cage on the 4,000 mark 12:29 p.m. Nov. 25, 2013 - Michael Ashbaugh
FDA clears Salix anti-diarrheal for HIV patients 7:59 a.m. Jan. 1, 2013 - MarketWatch.com
Salix Pharmaceuticals profit rises 8:27 a.m. Aug. 9, 2012 - MarketWatch.com
Hot Stocks to watch 7:27 a.m. Aug. 9, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:15 p.m. July 30, 2012 - MarketWatch
Progenics, Salix shares hit by FDA rejection 11:29 a.m. July 30, 2012 - Val Brickates Kennedy
Progenics, Salix tumble on FDA drug rejection 10:46 a.m. July 30, 2012 - Val Brickates Kennedy
LNKD trade provides a teachable moment 12:02 a.m. March 22, 2012 - The Trading Deck
Tuesday’s biggest gaining and declining stocks 5:58 p.m. Dec. 20, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 6:17 p.m. Nov. 9, 2011 - Kate Gibson
S&P 500 nails trendline resistance 11:44 a.m. Oct. 7, 2011 - Michael Ashbaugh
Trouble For Synergy Pharmaceuticals Shorts With Pending SP-333 Trial Results 7:24 p.m. Aug. 15, 2014 - Seeking Alpha
3 Health Care Stocks Pushing The Sector Higher 1:03 p.m. Aug. 15, 2014 - TheStreet.com
Watch For Today's Momo Momentum Stock: Salix Pharmaceuticals (SLXP) 10:17 a.m. Aug. 15, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ACT AGN GILD IRWD 9:00 a.m. Aug. 15, 2014 - InvestorPlace.com
Why Tax Inversions Won't Go Away 2:20 p.m. Aug. 13, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – INCY WST BIIB SLXP 1:45 p.m. Aug. 13, 2014 - InvestorPlace.com
Salix Pharmaceuticals, Ltd. (SLXP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 13, 2014 - Zacks.com
Repros Therapeutics Q2 Loss a Penny Wider than Expected - Analyst Blog 10:50 a.m. Aug. 12, 2014 - Zacks.com
Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog 9:20 a.m. Aug. 12, 2014 - Zacks.com
Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog 11:50 a.m. Aug. 11, 2014 - Zacks.com
Inversion Deals Are Costing The U.S. 8:58 a.m. Aug. 11, 2014 - Seeking Alpha
Leaders Actavis, Salix Trip Sell Signals 5:37 p.m. Aug. 8, 2014 - Investors Business Daily
Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales - Analyst Blog 4:10 p.m. Aug. 8, 2014 - Zacks.com
OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 8.2% - Tale of the Tape 9:39 a.m. Aug. 8, 2014 - Zacks.com
IGI, Laboratories (IG) Jumps: Stock Adds 6.7% in Session - Tale of the Tape 8:51 a.m. Aug. 8, 2014 - Zacks.com
Salix Sinks In #PreMarket On Disappointing Outlook, Q2 Results 8:19 a.m. Aug. 8, 2014 - benzinga.com
Sterne Agee Adjusts Estimates For Salix Pharmaceuticals 8:17 a.m. Aug. 8, 2014 - benzinga.com
Salix Pharmaceuticals' (SLXP) CEO Carolyn Logan on Q2 2014 Results - Earnings Call Transcript 8:10 p.m. Aug. 7, 2014 - Seeking Alpha
Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide 5:50 p.m. Aug. 7, 2014 - Investors Business Daily
Salix Pharmaceuticals (SLXP) Q2 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 7, 2014 - Seeking Alpha
Corporate Statements, Supplemental New Drug Application, Financial Result, and Technical Update - Research Reports on Allergan, Salix, Medivation, Valeant and AstraZeneca 9:20 a.m. Aug. 13, 2014 - PR Newswire - PRF
Salix Announces Important Topline Results for Microbiome, Culture & Susceptibility, and Key Secondary Efficacy Results for TARGET 3, Rifaximin IBS-D Repeat Treatment Study 2:01 p.m. Aug. 11, 2014 - BusinessWire - BZX
FDA Assigns September 29, 2014 Prescription Drug User Fee Act Goal Date for RELISTOR® Subcutaneous Injection sNDA for the Treatment of Opioid-induced Constipation in Patients with Chronic Non-cancer Pain 7:00 a.m. Aug. 11, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Reports 2Q2014 Results 4:02 p.m. Aug. 7, 2014 - BusinessWire - BZX
Lifshitz & Miller Law Firm Announces Investigation of Design Within Reach, Inc., Family Dollar Stores, Inc., GFI Group Inc., Intermountain Community Bancorp, Rockwood Holdings, Inc., and Salix Pharmaceuticals Ltd. 1:19 p.m. July 31, 2014 - PR Newswire - PRF
Salix Pharmaceuticals Announces 2Q2014 Financial Results Conference Call and Webcast 7:00 a.m. July 24, 2014 - BusinessWire - BZX
Pharma Stocks under Review -- Impax Laboratories, Sanofi, GW Pharma, AcelRx Pharma, and Salix Pharma 9:20 a.m. July 23, 2014 - PR Newswire - PRF
Salix and Pharming Announce FDA Approval of RUCONEST® for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE) 1:00 a.m. July 17, 2014 - BusinessWire - BZX
Progenics Holds Conference Call This Morning on FDA Appeal Response Regarding Relistor(R) sNDA for Patients With Chronic Non-Cancer Pain 7:05 a.m. July 14, 2014 - GlobeNewswire
FDA Office of Drug Evaluation III Approves Salix’s Request that the FDA Approve the RELISTOR® Subcutaneous Injection sNDA for the Treatment of Opioid-induced Constipation in Patients with Chronic Non-cancer Pain 7:00 a.m. July 14, 2014 - BusinessWire - BZX
Drug Application Submission, Merger Agreement, Launch of Newly Approved Drug, and Acquisition - Analyst Notes on Actavis, Salix, Mylan, Zoetis and Hospira 5:10 a.m. July 14, 2014 - PR Newswire - PRF
SALIX PHARMACEUTICALS, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger 11:42 a.m. July 10, 2014 - PR Newswire - PRF
SALIX SHAREHOLDER ALERT:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Merger between Salix and Cosmo Pharmaceuticals May be Unfair to Shareholders 11:30 a.m. July 10, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Salix Pharmaceuticals, Ltd. In Connection With The Proposed Sale Of The Company 6:10 p.m. July 9, 2014 - BusinessWire - BZX
SALIX ALERT: Proposed Sale of Salix Pharmaceuticals, Ltd. Being Investigated by Johnson & Weaver, LLP 1:32 p.m. July 9, 2014 - BusinessWire - BZX
Cadwalader Advising Salix Pharmaceuticals in its Combination with Cosmo Technologies to Form Salix Pharmaceuticals, plc 9:05 p.m. July 8, 2014 - BusinessWire - BZX
Salix Pharmaceuticals to Combine with Cosmo Technologies to Form Salix Pharmaceuticals, plc 5:00 p.m. July 8, 2014 - BusinessWire - BZX
Salix Announces Statistically Significant Primary Endpoint Result for TARGET 3 Evaluating the Efficacy and Safety of Repeat Treatment with Rifaximin 550mg in Subjects with Irritable Bowel Syndrome with Diarrhea 7:00 a.m. July 1, 2014 - BusinessWire - BZX
Patent Case Settlements, FDA Rulings, Upcoming Investor Day, Product Launching, and Closing of Offering - Analyst Notes on Teva, AstraZeneca, Salix, Mylan and GW 5:10 a.m. June 30, 2014 - PR Newswire - PRF
Salix Pharmaceuticals to Host Investor Day on July 9, 2014 7:00 a.m. June 25, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼
